Cargando…
Clinical Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
Eleven cases of neurological defects in T-ALL patients treated with nelarabine have been described in the last 4 years, seven of these after stem cell transplantation (SCT) for T Lymphoblastic Lymphoma (T-LBL). Most of these patients had an unfavorable outcome or irreversible neurological damage. We...
Autores principales: | Tisi, Maria Chiara, Ausoni, Giuseppe, Vita, Maria Gabriella, Tartaglione, Tommaso, Balducci, Mario, Laurenti, Luca, Chiusolo, Patrizia, Hohaus, Stefan, Sica, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344177/ https://www.ncbi.nlm.nih.gov/pubmed/25745552 http://dx.doi.org/10.4084/MJHID.2015.025 |
Ejemplares similares
-
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
por: Cooper, Todd M
Publicado: (2007) -
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
por: Shimony, Shai, et al.
Publicado: (2022) -
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
por: Reilly, Kelly M, et al.
Publicado: (2009) -
Rhabdomyolysis induced by nelarabine
por: Späth, Christian, et al.
Publicado: (2022) -
Nelarabine Associated Myotoxicity and Rhabdomyolysis
por: Haider, Mahnur, et al.
Publicado: (2015)